Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded down 3.2% on Tuesday . The stock traded as low as $0.77 and last traded at $1.21. 11,145 shares were traded during mid-day trading, an increase of 23% from the average session volume of 9,053 shares. The stock had previously closed at $1.25.
Peak Pharmaceuticals Stock Up 45.3 %
The company has a 50 day simple moving average of $2.17 and a two-hundred day simple moving average of $2.94.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Stories
- Five stocks we like better than Peak Pharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Investing in the High PE Growth Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Investing in Travel Stocks Benefits
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
